ArticleOncology reports2015

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts.

Hiroshi Tsukihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.